GlaxoSmithKline PLC Director/PDMR Shareholding (7967Z)
2020年1月15日 - 1:46AM
RNSを含む英国規制内ニュース (英語)
TIDMGSK
RNS Number : 7967Z
GlaxoSmithKline PLC
14 January 2020
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. Details of PDMR/person closely associated with them
('PCA')
==== ==============================================================================================
a) Name Mr B McNamara
==== ======================================== ====================================================
b) Position/status CEO, GSK Consumer Healthcare
==== ======================================== ====================================================
c) Initial notification/ Initial notification
amendment
==== ======================================== ====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ==============================================================================================
a) Name GlaxoSmithKline plc
==== ======================================== ====================================================
b) LEI 5493000HZTVUYLO1D793
==== ======================================== ====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ==============================================================================================
a) Description of American Depositary Shares ('ADSs')
the financial ISIN: US37733W1053
instrument
==== ======================================== ====================================================
b) Nature of the Acquisition of ADSs following the re-investment
transaction of dividends paid to shareholders on 9
January 2020 on ADSs held in the Deferred
Annual Bonus Plan Post-Tax.
==== ======================================== ====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ======================================== ====================== =========================
$47.0819 24.753
====================== =========================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
========================================= ========================================================
e) Date of the transaction 2020-01-10
==== ======================================== ====================================================
f) Place of the New York Stock Exchange (XNYS)
transaction
==== ======================================== ====================================================
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHQZLFFBFLZBBL
(END) Dow Jones Newswires
January 14, 2020 11:46 ET (16:46 GMT)
Gsk (LSE:GSK)
過去 株価チャート
から 3 2024 まで 4 2024
Gsk (LSE:GSK)
過去 株価チャート
から 4 2023 まで 4 2024